Trimetazidine, Administered at the Onset of Reperfusion, Ameliorates Myocardial Dysfunction and Injury by Activation of p38 Mitogen-Activated Protein Kinase and Akt Signaling
Mahmood Khan(Mayo Clinic), Periannan Kuppusamy(Dartmouth College)
Cited by 67
Related Papers
Pharmacological Preconditioning of Mesenchymal Stem Cells with Trimetazidine (1-[2,3,4-Trimethoxybenzyl]piperazine) Protects Hypoxic Cells against Oxidative Stress and Enhances Recovery of Myocardial Function in Infarcted Heart through Bcl-2 Expression
|Journal of Pharmacology and Experimental Therapeutics|2009|135
Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3
|International Journal of Cancer|2009|124
NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols
|Journal of Translational Medicine|2008|57
Amelioration of Doxorubicin-Induced Cardiotoxicity by an Anticancer-Antioxidant Dual-Function Compound, HO-3867
|Journal of Pharmacology and Experimental Therapeutics|2011|48
Scalable Biomimetic Coaxial Aligned Nanofiber Cardiac Patch: A Potential Model for “Clinical Trials in a Dish”
|Frontiers in Bioengineering and Biotechnology|2020|37